Patheon closes $255M Banner deal

With T's crossed and I's dotted, CDMO Patheon has closed its $255 million acquisition of Banner Pharmacaps, maker of gelatin-based dosage forms. Banner is the world's second-largest softgel producer, and Patheon says the deal will make it a leader in oral dosage development and manufacturing, and push it toward the $1 billion annual revenue mark. Release

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.